FIELD: medicine. SUBSTANCE: method involves administering eyconol at a dose of 2 mg 4 times a day during 4 weeks. EFFECT: improved metabolism characteristics; prevented complications. 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF ISCHEMIC STROKE PREVENTION ASSOSIATED WITH CHRONIC CEREBROVASCULAR INSUFFICIENCY OF ATHEROSCLEROTIC GENESIS | 2006 |
|
RU2329041C2 |
METHOD OF TREATMENT OF PATIENTS SUFFERING FROM ACUTE AND CHRONIC CEREBROVASCULAR DISEASES OF ATHEROSCLEROTIC GENESIS | 2006 |
|
RU2329042C2 |
THERAPEUTICAL AGENT, USES THEREOF AND METHOD FOR DISEASES TREATMENT AND PROPHYLAXIS | 2005 |
|
RU2306144C1 |
METHOD OF TREATMENT OF PATIENTS WITH DIABETIC RETINOPATHY | 1996 |
|
RU2140236C1 |
METHOD FOR TREATING ATHEROSCLEROSIS | 2006 |
|
RU2311209C1 |
METHOD OF ISHEMIC CEREBROVASCULAR DISEASES TREATMENT | 2006 |
|
RU2327494C1 |
METHOD OF INTEGRATED TREATMENT OF PATIENTS WITH DISCIRCULATORY ENCEPHALOPATHY | 2011 |
|
RU2449822C1 |
SPECIES FOR TREATMENT OF PATIENTS WITH VASCULAR DISEASES AND DISTURBANCE OF LIPID METABOLISM | 2002 |
|
RU2227040C1 |
HERBAL TEA FOR PREVENTION OF PRIMARY ISCHEMIC STROKE IN PATIENTS WITH CEREBROVASCULAR DISEASE | 2013 |
|
RU2542423C1 |
AGENT ELICITING ANTIHYPERLIPOPROTEINEMIC ACTIVITY, FOOD SUPPLEMENT BASED ON THEREOF AND METHOD OF TREATMENT OF LIPID METABOLISM DISTURBANCE IN PATIENTS WITH CARDIOVASCULAR DISEASES | 2001 |
|
RU2201239C1 |
Authors
Dates
1996-10-27—Published
1992-03-19—Filed